WEST PHARMACEUTICAL SERVICES, INC. West Pharmaceutical Services, Inc. Stock
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318.7 USD | -3.05% |
|
-2.28% | -9.12% |
Financials (USD)
| Sales 2024 * | 3.01B | Sales 2025 * | 3.28B | Capitalization | 23.95B |
|---|---|---|---|---|---|
| Net income 2024 * | 573M | Net income 2025 * | 672M | EV / Sales 2024 * | 7.75 x |
| Net cash position 2024 * | 617M | Net cash position 2025 * | 1.02B | EV / Sales 2025 * | 6.99 x |
| P/E ratio 2024 * |
42.6
x | P/E ratio 2025 * |
37
x | Employees | 10,600 |
| Yield 2024 * |
0.28% | Yield 2025 * |
0.34% | Free-Float | 96.38% |
More Fundamentals
* Assessed data
More news
Latest transcript on West Pharmaceutical Services, Inc.
More recommendations
More press releases
More news
| 1 day | -2.99% | ||
| 1 week | -2.28% | ||
| Current month | -3.44% | ||
| 1 month | -12.70% | ||
| 3 months | -10.81% | ||
| 6 months | -8.80% | ||
| Current year | -9.12% |
1 week
318.27
334.72
1 month
318.27372.52
Current year
318.27413.70
1 year
310.42415.73
3 years
206.19475.35
5 years
116.37475.35
10 years
39.11475.35
| Managers | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 15-04-23 |
Bernard Birkett
DFI | Director of Finance/CFO | 55 | 18-06-20 |
Silji Abraham
CTO | Chief Tech/Sci/R&D Officer | 52 | 18-02-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Michels
BRD | Director/Board Member | 66 | 11-01-31 |
Eric Green
CEO | Chief Executive Officer | 55 | 15-04-23 |
Paolo Pucci
BRD | Director/Board Member | 63 | 16-09-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.04% | 5 M€ | -1.80% | - | |
| 1.44% | 14 M€ | -5.04% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-04 | 320 | -2.66% | 346 623 |
| 24-06-03 | 328.7 | -0.81% | 434,824 |
| 24-05-31 | 331.4 | +0.70% | 767,681 |
| 24-05-30 | 329.1 | +1.94% | 491,437 |
| 24-05-29 | 322.8 | -1.41% | 465,937 |
Delayed Quote Nyse, June 04, 2024 at 03:16 pm EDT
More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows:
- own manufactured products (81.8%);
- products manufactured under contract (18.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
328.7
USD
Average target price
397.1
USD
Spread / Average Target
+20.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.12% | 23.95B | |
| -6.23% | 179B | |
| +0.96% | 108B | |
| -1.94% | 69.03B | |
| -6.45% | 45.83B | |
| +12.54% | 45.39B | |
| +8.60% | 43.17B | |
| +15.73% | 29.89B | |
| +13.65% | 25.49B | |
| -6.85% | 23.27B |
- Stock Market
- Equities
- WST Stock
